Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Mar 2024 for Design Therapeutics, Inc., €4,502.
Filing timeline
BuySaleHeather A. Berger
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +16.2%Entry US$3.57 · Close at T+365 US$4.15
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Heather A. Berger: trading record in brief
Heather A. Berger has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Entasis Therapeutics Holdings Inc. and Design Therapeutics, Inc. We count 3 filings; the first trade dates from 7 July 2022 and the latest from 25 March 2024.
Purchases make up the whole of the open-market record (1 purchase, €4,502). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2024: 1 purchase and no sales on the market.
The record was last updated on 25 March 2024 with an open-market purchase (€4,502) in Design Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Heather A. Berger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
1,300 shares@ US$3.7429100.0% of flowCommon StockSEC:0001415889-24-009062:0
Canonical exit: 23 Jun 2024 (T+90)
27,500 shares@ US$2.2055.9% of flowCommon StockSEC:0001104659-22-078788:1
22,000 shares@ US$2.20100.0% of flowCommon StockSEC:0001104659-22-078788:0
3 of 1 declaration
